Free and cued selective reminding test predicts progression to Alzheimer’s disease in people with mild cognitive impairment

Giulia Grande, Nicola Vanacore, Davide L. Vetrano, Ilaria Cova, Debora Rizzuto, Flavia Mayer, Laura Maggiore, Roberta Ghiretti, Valentina Cucumo, Claudio Mariani, Stefano F. Cappa, Simone Pomati

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Introduction: To assess the diagnostic accuracy of the free and cued selective reminding test (FCSRT) for the development of Alzheimer’s disease (AD) in people with mild cognitive impairment (MCI). Methods: We enrolled 187 consecutive MCI outpatients from a memory clinic that were evaluated at baseline and every 6 to 12 months through an extensive clinical and neuropsychological protocol. For each test, measures of diagnostic accuracy were obtained. To improve the overall specificity of the neuropsychological battery, we also used the diagnostic tests in parallel combination. The association between FCSRT indexes and AD was tested through proportional hazard regression models with other dementia subtypes as competing event. Laplace regression was used to model time-to-AD diagnosis as a function of FCSRT indexes. Results: The area under the curve of the FCSRT indexes ranged from 0.69 (95% CI: 0.62–0.76) to 0.76 (95% CI: 0.70–0.82). The specificity peaked up to 100% when we combined the category fluency test with the delayed total recall index of the FCSRT. Participants who tested positive at the FCSRT, as compared with those with negative tests, presented a twofold to fivefold higher risk of developing AD (median follow-up time 2.5 years; p < 0.001) and were diagnosed with AD 2–3 years earlier (p < 0.001). Discussion: The FCSRT assessment suite shows the best predictive performance in detecting AD in people with MCI. These findings might help to reliably and timely identify people at higher risk of AD that is crucial both for properly selecting participants to clinical trials and to fine tune an effective and patient-centered care.

Original languageEnglish
Pages (from-to)1867-1875
Number of pages9
JournalNeurological Sciences
Volume39
Issue number11
DOIs
Publication statusPublished - Nov 1 2018

Fingerprint

Alzheimer Disease
Free Association
Patient-Centered Care
Clinical Protocols
Cognitive Dysfunction
Proportional Hazards Models
Routine Diagnostic Tests
Area Under Curve
Dementia
Outpatients
Clinical Trials

Keywords

  • Alzheimer’s disease
  • Free and cued selective reminding test
  • Longitudinal study
  • Mild cognitive impairment

ASJC Scopus subject areas

  • Dermatology
  • Clinical Neurology
  • Psychiatry and Mental health

Cite this

Free and cued selective reminding test predicts progression to Alzheimer’s disease in people with mild cognitive impairment. / Grande, Giulia; Vanacore, Nicola; Vetrano, Davide L.; Cova, Ilaria; Rizzuto, Debora; Mayer, Flavia; Maggiore, Laura; Ghiretti, Roberta; Cucumo, Valentina; Mariani, Claudio; Cappa, Stefano F.; Pomati, Simone.

In: Neurological Sciences, Vol. 39, No. 11, 01.11.2018, p. 1867-1875.

Research output: Contribution to journalArticle

Grande, G, Vanacore, N, Vetrano, DL, Cova, I, Rizzuto, D, Mayer, F, Maggiore, L, Ghiretti, R, Cucumo, V, Mariani, C, Cappa, SF & Pomati, S 2018, 'Free and cued selective reminding test predicts progression to Alzheimer’s disease in people with mild cognitive impairment', Neurological Sciences, vol. 39, no. 11, pp. 1867-1875. https://doi.org/10.1007/s10072-018-3507-y
Grande, Giulia ; Vanacore, Nicola ; Vetrano, Davide L. ; Cova, Ilaria ; Rizzuto, Debora ; Mayer, Flavia ; Maggiore, Laura ; Ghiretti, Roberta ; Cucumo, Valentina ; Mariani, Claudio ; Cappa, Stefano F. ; Pomati, Simone. / Free and cued selective reminding test predicts progression to Alzheimer’s disease in people with mild cognitive impairment. In: Neurological Sciences. 2018 ; Vol. 39, No. 11. pp. 1867-1875.
@article{b4b86c05e35b46a097f54126790061b9,
title = "Free and cued selective reminding test predicts progression to Alzheimer’s disease in people with mild cognitive impairment",
abstract = "Introduction: To assess the diagnostic accuracy of the free and cued selective reminding test (FCSRT) for the development of Alzheimer’s disease (AD) in people with mild cognitive impairment (MCI). Methods: We enrolled 187 consecutive MCI outpatients from a memory clinic that were evaluated at baseline and every 6 to 12 months through an extensive clinical and neuropsychological protocol. For each test, measures of diagnostic accuracy were obtained. To improve the overall specificity of the neuropsychological battery, we also used the diagnostic tests in parallel combination. The association between FCSRT indexes and AD was tested through proportional hazard regression models with other dementia subtypes as competing event. Laplace regression was used to model time-to-AD diagnosis as a function of FCSRT indexes. Results: The area under the curve of the FCSRT indexes ranged from 0.69 (95{\%} CI: 0.62–0.76) to 0.76 (95{\%} CI: 0.70–0.82). The specificity peaked up to 100{\%} when we combined the category fluency test with the delayed total recall index of the FCSRT. Participants who tested positive at the FCSRT, as compared with those with negative tests, presented a twofold to fivefold higher risk of developing AD (median follow-up time 2.5 years; p < 0.001) and were diagnosed with AD 2–3 years earlier (p < 0.001). Discussion: The FCSRT assessment suite shows the best predictive performance in detecting AD in people with MCI. These findings might help to reliably and timely identify people at higher risk of AD that is crucial both for properly selecting participants to clinical trials and to fine tune an effective and patient-centered care.",
keywords = "Alzheimer’s disease, Free and cued selective reminding test, Longitudinal study, Mild cognitive impairment",
author = "Giulia Grande and Nicola Vanacore and Vetrano, {Davide L.} and Ilaria Cova and Debora Rizzuto and Flavia Mayer and Laura Maggiore and Roberta Ghiretti and Valentina Cucumo and Claudio Mariani and Cappa, {Stefano F.} and Simone Pomati",
year = "2018",
month = "11",
day = "1",
doi = "10.1007/s10072-018-3507-y",
language = "English",
volume = "39",
pages = "1867--1875",
journal = "Neurological Sciences",
issn = "1590-1874",
publisher = "Springer-Verlag Italia s.r.l.",
number = "11",

}

TY - JOUR

T1 - Free and cued selective reminding test predicts progression to Alzheimer’s disease in people with mild cognitive impairment

AU - Grande, Giulia

AU - Vanacore, Nicola

AU - Vetrano, Davide L.

AU - Cova, Ilaria

AU - Rizzuto, Debora

AU - Mayer, Flavia

AU - Maggiore, Laura

AU - Ghiretti, Roberta

AU - Cucumo, Valentina

AU - Mariani, Claudio

AU - Cappa, Stefano F.

AU - Pomati, Simone

PY - 2018/11/1

Y1 - 2018/11/1

N2 - Introduction: To assess the diagnostic accuracy of the free and cued selective reminding test (FCSRT) for the development of Alzheimer’s disease (AD) in people with mild cognitive impairment (MCI). Methods: We enrolled 187 consecutive MCI outpatients from a memory clinic that were evaluated at baseline and every 6 to 12 months through an extensive clinical and neuropsychological protocol. For each test, measures of diagnostic accuracy were obtained. To improve the overall specificity of the neuropsychological battery, we also used the diagnostic tests in parallel combination. The association between FCSRT indexes and AD was tested through proportional hazard regression models with other dementia subtypes as competing event. Laplace regression was used to model time-to-AD diagnosis as a function of FCSRT indexes. Results: The area under the curve of the FCSRT indexes ranged from 0.69 (95% CI: 0.62–0.76) to 0.76 (95% CI: 0.70–0.82). The specificity peaked up to 100% when we combined the category fluency test with the delayed total recall index of the FCSRT. Participants who tested positive at the FCSRT, as compared with those with negative tests, presented a twofold to fivefold higher risk of developing AD (median follow-up time 2.5 years; p < 0.001) and were diagnosed with AD 2–3 years earlier (p < 0.001). Discussion: The FCSRT assessment suite shows the best predictive performance in detecting AD in people with MCI. These findings might help to reliably and timely identify people at higher risk of AD that is crucial both for properly selecting participants to clinical trials and to fine tune an effective and patient-centered care.

AB - Introduction: To assess the diagnostic accuracy of the free and cued selective reminding test (FCSRT) for the development of Alzheimer’s disease (AD) in people with mild cognitive impairment (MCI). Methods: We enrolled 187 consecutive MCI outpatients from a memory clinic that were evaluated at baseline and every 6 to 12 months through an extensive clinical and neuropsychological protocol. For each test, measures of diagnostic accuracy were obtained. To improve the overall specificity of the neuropsychological battery, we also used the diagnostic tests in parallel combination. The association between FCSRT indexes and AD was tested through proportional hazard regression models with other dementia subtypes as competing event. Laplace regression was used to model time-to-AD diagnosis as a function of FCSRT indexes. Results: The area under the curve of the FCSRT indexes ranged from 0.69 (95% CI: 0.62–0.76) to 0.76 (95% CI: 0.70–0.82). The specificity peaked up to 100% when we combined the category fluency test with the delayed total recall index of the FCSRT. Participants who tested positive at the FCSRT, as compared with those with negative tests, presented a twofold to fivefold higher risk of developing AD (median follow-up time 2.5 years; p < 0.001) and were diagnosed with AD 2–3 years earlier (p < 0.001). Discussion: The FCSRT assessment suite shows the best predictive performance in detecting AD in people with MCI. These findings might help to reliably and timely identify people at higher risk of AD that is crucial both for properly selecting participants to clinical trials and to fine tune an effective and patient-centered care.

KW - Alzheimer’s disease

KW - Free and cued selective reminding test

KW - Longitudinal study

KW - Mild cognitive impairment

UR - http://www.scopus.com/inward/record.url?scp=85050675645&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050675645&partnerID=8YFLogxK

U2 - 10.1007/s10072-018-3507-y

DO - 10.1007/s10072-018-3507-y

M3 - Article

C2 - 30051200

AN - SCOPUS:85050675645

VL - 39

SP - 1867

EP - 1875

JO - Neurological Sciences

JF - Neurological Sciences

SN - 1590-1874

IS - 11

ER -